Infinity Pharmaceuticals | INFI - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 12.54B 474M 2026-03
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Cipla INR 41.64B 6.31B 2025-12
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Eisai JPY 168.85B 17.02B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Grifols EUR 766.49M 39.74M 2024-12
Incyte USD 1.17B 217.51M 2026-03
Infinity Pharmaceuticals USD 231K 59K 2023-06
Ionis Pharmaceuticals USD 243M 48M 2026-03
J&J USD 17.24B 642M 2026-03
Novartis USD 10.07B 184M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Plus Therapeutics 1.37M 30K 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
TG Therapeutics USD 171.41M 16.98M 2026-03